Automated detection of may predict disease progression, a longitudinal analysis suggested. (Alzheimer's & Dementia)
More blood pressure-lowering medications than those included in treatment guidelines frequency. (Cephalalgia)
Olfactory dysfunction of subsequent depressive symptoms. (Journals of Gerontology: Series A)
Cholinesterase inhibitors were tied to small improvements on in Alzheimer's disease and Parkinson's disease, a meta-analysis suggested. (JAMA Neurology)
Atrial fibrillation was associated with to mild cognitive impairment and dementia in women. (Alzheimer's & Dementia)
The FDA approved argenx's (Vyvgart Hytrulo) for generalized myasthenia gravis patients who are anti-acetylcholine receptor antibody positive, Halozyme Therapeutics said.
CMS of its plan to cover new Alzheimer's drugs.
Experts discussed (Leqembi) if the anti-amyloid Alzheimer's drug wins full FDA approval next week -- and who might not. (NPR)
The Semont-plus maneuver was superior to the Epley maneuver in terms of the number of days until recovery in posterior canal . (JAMA Neurology)
New multiple sclerosis (MS) lesions that evolved into may be identified early. (Annals of Neurology)
People with progressive MS had a than those with relapsing remitting MS (RRMS), and anti-CD20 therapies in RRMS were associated with severe COVID-19. (JAMA Network Open)
A multilevel analysis of the gut-brain axis showed and specific microbial profiles. (Nature Neuroscience)